Back to search
FDAFDA · Food and drugs·Recall number D-0572-2026

HyVee, Ultra Strength Antacid, Calcium Carbonate 1000 mg, 72 CHEWABLE TABLETS, DISTRIBUTED BY: HY-VEE INC., Inc., WEST DES MOINES, IA 50266, UPC: 0 75450 82514 5.

Published June 10, 2026 · Recall initiated: May 28, 2026

Summary

FDA records drug Class II recall D-0572-2026, published June 10, 2026 and initiated May 28, 2026. Recalling firm: Guardian Drug Co. Inc.; Status: Ongoing; Lot: Lot #: 1716089, expires: JAN 2029. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of foreign substance: small metallic particles in chewable tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Guardian Drug Co. Inc.
Distributor
U.S.A. Nationwide
Lot
Lot #: 1716089, expires: JAN 2029.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was HyVee, Ultra Strength Antacid, Calcium Carbonate 1000 mg, 72 CHEWABLE TABLETS, DISTRIBUTED BY: HY-VEE INC., Inc., WEST DES MOINES, IA 50266, UPC: 0 75450 82514 5. recalled?

Yes. FDA published recall D-0572-2026 on June 10, 2026. Reported hazard: Presence of foreign substance: small metallic particles in chewable tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter